Newsroom
All news stories
Latest news

Featured
Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and dev...
Press Release, Corporate
28 June 2025
- Notice of results Press Release, Financial Results 09 July 2025 Notice of results
- Hikma receives FDA approval for TYZAVANTM (Vancomycin Injection, USP) in the US Press Release, Product 02 July 2025 Hikma receives FDA approval for TYZAVANTM (Vancomycin Injection, USP) in the US
- Hikma publishes its 2024 Sustainability Report reinforcing commitment to global access to medicines Press Release, Corporate 30 June 2025 Hikma publishes its 2024 Sustainability Report reinforcing commitment to global access to medicines
- Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines Press Release, Corporate 28 June 2025 Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines
